| 发明名称 |
TREATMENT OF ERYTHROPOIETIN (EPO) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO EPO |
| 摘要 |
Oligonucleotide compounds modulate expression and/or function of Erythropoietin (EPO) polynucleotides and encoded products thereof. Methods for treating diseases associated with Erythropoietin (EPO) comprise administering one or more oligonucleotide compounds designed to inhibit the EPO natural antisense transcript to patients.
|
| 申请公布号 |
US2011237651(A1) |
申请公布日期 |
2011.09.29 |
| 申请号 |
US200913133025 |
申请日期 |
2009.12.03 |
| 申请人 |
OPKO CURNA, LLC |
发明人 |
COLLARD JOSEPH;SHERMAN OLGA KHORKOVA |
| 分类号 |
A61K31/7088;A61K31/7115;A61K31/712;A61K31/7125;A61K31/713;A61P7/00;A61P7/06;A61P9/00;A61P9/02;A61P9/04;A61P9/10;A61P9/12;A61P11/00;A61P13/00;A61P13/12;A61P15/00;A61P25/00;A61P25/02;A61P25/08;A61P25/16;A61P25/18;A61P25/22;A61P25/24;A61P25/28;A61P25/32;A61P27/02;A61P27/06;A61P29/00;A61P31/00;A61P35/00;A61P37/00;A61P37/06;A61P43/00;C07H21/00;C12N5/071;G01N33/15 |
主分类号 |
A61K31/7088 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
